Rochester, Minnesota
United States
21
2024-10-24
The entities that hold a legal rights for patent applications filed by inventor STROME Scott E.:
Scott E. STROME from Rochester, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#2 | 2021-12-09Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#3 | 2020-01-02Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#4 | 2018-06-28COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#5 | 2018-04-12COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#6 | 2016-09-15COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#7 | 2016-09-08COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#8 | 2016-08-25Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#9 | 2015-02-12COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#10 | 2012-03-08METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
#11 | 2012-02-02METHODS OF ENHANCING T CELL RESPONSIVENESS
#12 | 2011-08-18B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#13 | 2011-05-05METHOD OF USING AN ANTI-CD137 ANTIBODY AS AN AGENT FOR RADIOIMMUNOTHERAPY OR RADIOIMMUNODETECTION
#14 | 2010-10-21Enhancement of immune responses by 4-1BB-binding agents
#15 | 2010-09-14Methods of enhancing T cell responsiveness
#16 | 2008-11-11Detection of antibodies specific for B7-H1 in subjects with diseases or pathological conditions mediated by activated T cells
#17 | 2008-01-24Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
#18 | 2006-08-24Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
#19 | 2006-08-17Anti-CD137 antibody as an agent in the treatment of cancer and glycosylation variants thereof
#20 | 2006-04-20B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
#21 | 2005-01-20Enhancement of immune responses by 4-1bb-binding agents
1065385 ⎘